Search Results - "Boggio, Katia"

  • Showing 1 - 10 results of 10
Refine Results
  1. 1

    Nonredundant roles of antibody, cytokines, and perforin in the eradication of established Her-2/neu carcinomas by Curcio, Claudia, Di Carlo, Emma, Clynes, Raphael, Smyth, Mark J, Boggio, Katia, Quaglino, Elena, Spadaro, Michela, Colombo, Mario P, Amici, Augusto, Lollini, Pier-Luigi, Musiani, Piero, Forni, Guido

    Published in The Journal of clinical investigation (01-04-2003)
    “…Since the mechanisms by which specific immunity destroys Her-2/neu carcinoma cells are highly undetermined, these were assessed in BALB/c mice vaccinated with…”
    Get full text
    Journal Article
  2. 2

    Interleukin 12-mediated prevention of spontaneous mammary adenocarcinomas in two lines of Her-2/neu transgenic mice by Boggio, K, Nicoletti, G, Di Carlo, E, Cavallo, F, Landuzzi, L, Melani, C, Giovarelli, M, Rossi, I, Nanni, P, De Giovanni, C, Bouchard, P, Wolf, S, Modesti, A, Musiani, P, Lollini, P L, Colombo, M P, Forni, G

    Published in The Journal of experimental medicine (03-08-1998)
    “…The ability of interleukin (IL)-12 to prevent tumors when administered to individuals with a genetic risk of cancer was studied in two lines of transgenic mice…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Analysis of mammary carcinoma onset and progression in HER-2/neu oncogene transgenic mice reveals a lobular origin by Di Carlo, E, Diodoro, M G, Boggio, K, Modesti, A, Modesti, M, Nanni, P, Forni, G, Musiani, P

    Published in Laboratory investigation (01-10-1999)
    “…Morphologic examinations of mammary neoplasias arising in BALB/c (H-2d) mice carrying the activated rat HER-2/neu oncogene (BALB-NeuT), and in FVB (H-2q) mice…”
    Get more information
    Journal Article
  5. 5

    Ability of systemic interleukin-12 to hamper progressive stages of mammary carcinogenesis in HER2/neu transgenic mice by BOGGIO, K, DI CARLO, E, FORNI, G, ROVERO, S, CAVALLO, F, QUAGLINO, E, LOLLINI, P. L, NANNI, P, NICOLETTI, G, WOLF, S, MUSIANI, P

    Published in Cancer research (Chicago, Ill.) (15-01-2000)
    “…Previous studies in mice have shown that chronic administration of recombinant interleukin-12 (IL-12) hampers the progression of both chemical- and…”
    Get full text
    Journal Article
  6. 6

    A light, nontoxic interleukin 12 protocol inhibits HER-2/neu mammary carcinogenesis in BALB/c transgenic mice with established hyperplasia by CIFALDI, Loredana, QUAGLINO, Elena, DI CARLO, Emma, MUSIANI, Piero, SPADARO, Michela, LOLLINI, Pier Luigi, WOLF, Stanley, BOGGIO, Katia, FORNI, Guido, CAVALLO, Federica

    Published in Cancer research (Chicago, Ill.) (01-04-2001)
    “…With a slight asynchronous but consistent progression, all of the mammary glands of female BALB/c mice transgenic for the transforming rat HER-2/neu oncogene…”
    Get full text
    Journal Article
  7. 7

    Inhibition of mammary carcinogenesis by systemic interleukin 12 or p185neu DNA vaccination in Her-2/neu transgenic BALB/c mice by DI CARLO, Emma, ROVERO, Stefania, BOGGIO, Katia, QUAGLINO, Elena, AMICI, Augusto, SMORLESI, Arianna, FORNI, Guido, MUSIANI, Piero

    Published in Clinical cancer research (01-03-2001)
    “…Because BALB/c mice transgenic for the rat Her-2/neu oncogene develop multifocal carcinomas in all mammary glands by week 33, they constitute an aggressive…”
    Get full text
    Conference Proceeding Journal Article
  8. 8

    Inhibition of Mammary Carcinogenesis by Systemic Interleukin 12 or pl85neu DNA Vaccination in Her-2/neu Transgenic BALB/c Mice by Emma Di Carlo, Stefania Rovero, Katia Boggio, Elena Quaglino, Augusto Amici, Arianna Smorlesi, Guido Forni, Piero Musiani

    Published in Clinical cancer research (01-03-2001)
    “…Because BALB/c mice transgenic for the rat Her-2/ neu oncogene develop multifocal carcinomas in all mammary glands by week 33, they constitute an aggressive…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Cytokine gene-engineered vaccines by Forni, G, Boggio, K

    Published in Current opinion in molecular therapeutics (01-02-1999)
    “…Cytokines modulate immune reactivity and have therefore been used to build cancer vaccines. Experimental vaccination of rodents and humans with cytokine-gene…”
    Get more information
    Journal Article